Policy and Education Assistant, British Ecological Society, London

New technology shows diabetes (EurekAlert, 21 January 2013)

Novo Nordisk gets green light for Tresiba in Europe (Reuters, 22 January 2013)

23 Jan 2013

The European Commission has reportedly approved marketing authorisation for Novo's insulin degludec (Tresiba) and insulin-degludec in combination with insulin aspart (Ryzodeq).

Related Topics

Adrenal Diabetes Metabolism Obesity Cardiovascular Bone Endocrine-Disrupting Chemicals Endocrine-Related Cancer Neuroendocrinology Reproduction Steroid and Steroidogenesis Thyroid

Share this story

Top stories

Call for nominations for Awards Committee Chair
30 Oct 2024

James M Tanner Award - 2025 nominations open
30 Oct 2024

Would you like to host the BSPED annual meeting?
21 Oct 2024

Most read